Bionomics Limited
BNOEF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.16K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $64,158.00 |
|---|---|
| Enterprise Value | $-19,767,028.00 |
| Earnings per Share | $-0.01 |
| Beta | 1.84 |
| Outstanding Shares | 10,693,000 |
Return
| Return on Equity | -54.68% |
|---|---|
| Return on Assets | -46.86% |
| Return on Invested Capital | -39.67% |
Valuation & Multiples
| P/E Ratio | -0.46 |
|---|---|
| PEG | 0.47 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -12.67 |
| Enterprise Value to EBIT | 1.34 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bionomics Ltd.
1 employees
CEO: Spyridon Papapetropoulos
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals l...